SM
VAXX

Scoggin Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Scoggin Management’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-150,000
Closed -$206K – 95
2023
Q3 		$206K Hold
150,000
– – 0.28% 59
2023
Q2 		$378K Hold
150,000
– – 0.68% 38
2023
Q1 		$341K Buy
150,000
+650
+0.4% +$1.65K 0.5% 43
2022
Q4 		$209K Sell
149,350
-101,819
-41% -$171K 0.27% 38
2022
Q3 		$497K Sell
251,169
-30,000
-11% -$62.4K 0.83% 32
2022
Q2 		$441K Hold
281,169
– – 0.69% 38
2022
Q1 		$1.21M Hold
281,169
– – 1.16% 36
2021
Q4 		$1.58M Buy
+281,169
New +$2.91M 1.21% 36

Other funds holding VAXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return